HIN heartware international, inc

re: Ann: HeartWare Announces Date for FDA Adv......

  1. 4,131 Posts.
    re: Ann: HeartWare Announces Date for FDA Adv... http://www.zacks.com/stock/news/71795/Thoratec+Downgraded+to+Neutral+-+Analyst+Blog However, there is no imminent competitive threat from HeartWare in the DT segment as its product is not expected to be launched till 2015. It appears that the hyper-growth phase enjoyed by Thoratec has stabilized to more normalized growth. Thoratec has demonstrated expertise in product development even as HeartWare is expected to close the technological gap.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.